Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine micro-emulsion conversion in transplant recipients with NODM
NCT00150085Phase 4Terminated
- Sponsor
- Novartis
- Start
- Feb 2004
- Primary completion
- Oct 2005
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 4 trial of cyclosporine in diabetes mellitus (DM), sponsored by Novartis. Started Feb 2004; status: terminated.
02
Drugs
cyclosporine
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT00150085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150085.